What makes the deadliest form of malaria specific to people?

The biological interactions that make some malaria parasites specific to host species

What makes the deadliest form of malaria specific to people?

malariaspecificity.jpgwww.pnas.org/cgi/doi/10.1073/pnas.1320771110
Interactions between PfRH5 and primate BSG orthologs are species specific. (A) Binding of PfRH5 to human (HsBSG), chimpanzee (PtBSG), and gorilla (GgBSG) BSG

Researchers have discovered why the parasite that causes the deadliest form of malaria only infects humans.

The team recently showed that the interaction between a parasite protein called RH5 and a receptor called basigin was essentially required for the invasion of red blood cells by the parasite that causes the deadliest form of malaria. Now, they've discovered that this same interaction is also an important factor in explaining why the parasite seems to be remarkably specific to humans. This research will help guide eradication strategies in regions where malaria is endemic.

There are several distinct species of parasite that cause malaria. The malaria parasite species responsible for severe illness and death, Plasmodium falciparum, only infects humans, but is closely related to several species that infect chimpanzees and gorillas. Strangely, these species seem to be very specific - individual species appear to infect only humans, chimpanzees or gorillas, even when these primates live in close proximity. This striking observation piqued the curiosity of the team which prompted a search for the molecules that control this specificity and revealed the important role of the RH5-basigin interaction.

"It's remarkable that the interaction of a single pair of proteins can explain why the most deadly form of malaria is specific to humans. This research will strengthen eradication strategies by ruling out great apes as possible reservoirs of human infection by P. falciparum."

Dr Julian Rayner, from the Wellcome Trust Sanger Institute Malaria Programme

The team investigated the question of host specificity by examining two important protein interactions involved in the invasion of red blood cells - the interactions between the parasite and host EBA175-Glycophorin A and RH5-basigin.

They found that the EBA175 protein from chimpanzee-specific malaria parasites could bind to human Glycophorin A, thereby ruling out this interaction as a specificity factor.

However, the RH5 protein from P. falciparum did not bind to the gorilla basigin protein and only bound extremely weakly to chimpanzee basigin. Therefore, the species specificity of this interaction mirrored the known infection profile of P. falciparum and provided a molecular explanation for why P. falciparum only infects humans.

"This interaction seems to explain why P. falciparum only infects people and not apes. This may also be an important guiding factor in the development of eradication strategies for the elimination of P. falciparum in endemic areas."

Professor Beatrice Hahn, author from the University of Pennsylvania

Until recently, studying protein interactions between the malaria parasite and great apes has been challenging. Both chimpanzees and gorillas are protected species and so obtaining blood samples that would help answer these questions is incredibly difficult.

"Today, we can produce these proteins synthetically in the laboratory to avoid the use of blood samples from endangered animals. In time, these scientific advances will lead to improved treatments, eradication strategies and, vaccine development for one of the world's major health problems."

Dr Gavin Wright, lead author from the Wellcome Trust Sanger Institute

Notes to Editors
Publications
  • RH5-Basigin interaction plays a major role in the host tropism of Plasmodium falciparum.

    Wanaguru M, Liu W, Hahn BH, Rayner JC and Wright GJ

    Proceedings of the National Academy of Sciences of the United States of America 2013;110;51;20735-40

Funding

This work was supported by the Wellcome Trust, Medical Research Council, the University of Pennsylvania Center for AIDS Research Single Genome Amplification Core Facility, and National Institutes of Health.

Participating Centres
  • Cell Surface Signalling Laboratory and Malaria Programme, Wellcome Trust Sanger Institute, Cambridge CB10 1SA, United Kingdom
  • Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
Selected Websites
Contact the Press Office

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Emily Mobley, Media Officer

Tel +44 (0)1223 496 851

Wellcome Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0) 7900 607793

Recent News

Low doses of radiation promote cancer-capable cells
New research in mice helps to understand the risks around exposure to low doses of radiation, such as CT scans and x-rays
Chan Zuckerberg Initiative boosts Human Cell Atlas research at the Sanger Institute
Seed Networks projects will focus on specific tissues, such as the thymus, lung, liver, kidney and immune system
Widely-available antibiotics could be used in the treatment of ‘superbug’ MRSA
Genomic analysis shows that a significant number of strains are susceptible to penicillin combined with clavulanic acid